About
Personalized Diagnostics
Areas of Focus
Categories
Diagnostics
Team (12)
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
0
As Collaborator
5
Total Enrollment
628
By Phase
PHASE3: 1NA: 1PHASE2: 1
By Status
RECRUITING: 4ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06584396Collaborator
Evaluating Mechanical Properties of Post-Mastectomy Skin Flaps to Estimate Reconstruction Risks, the EMPOWER Study
N/AActive, not recruiting
140 participants
Started: Sep 20, 2023 · Completed: Aug 30, 2027
NCT05406232Collaborator
Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer
N/ARecruiting
12 participants
Started: Sep 15, 2023 · Completed: Dec 31, 2026
NCT05774678Collaborator
Trial Of PreoperAtive Radiation (TOPAz): A Randomized Trial Comparing Hypofractionated Versus Conventionally Fractionated Preoperative Radiation Followed by Mastectomy With Immediate Autologous Breast Reconstruction With Integrated Nanomechanical Biomarker Evaluation
PHASE3Recruiting
126 participants
Started: Apr 5, 2023 · Completed: Nov 1, 2028
NCT02945579Collaborator
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
NARecruiting
120 participants
Started: Jan 20, 2017 · Completed: Jan 31, 2026
NCT02710253Collaborator
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
PHASE2Recruiting
230 participants
Started: May 25, 2016 · Completed: May 30, 2026
Locations (1)
Headquarters
Basel, Switzerland
Map
Loading map...